DK1532152T3 - Ny polymorf af N-methyl-N- (3- (3- [2-thienylcarbonyl]-pyrazol- [1,5-alfa]-pyrimidin-7-yl) phenyl) acetamid og beslægtede sammensætninger og metoder - Google Patents

Ny polymorf af N-methyl-N- (3- (3- [2-thienylcarbonyl]-pyrazol- [1,5-alfa]-pyrimidin-7-yl) phenyl) acetamid og beslægtede sammensætninger og metoder

Info

Publication number
DK1532152T3
DK1532152T3 DK03749163T DK03749163T DK1532152T3 DK 1532152 T3 DK1532152 T3 DK 1532152T3 DK 03749163 T DK03749163 T DK 03749163T DK 03749163 T DK03749163 T DK 03749163T DK 1532152 T3 DK1532152 T3 DK 1532152T3
Authority
DK
Denmark
Prior art keywords
thienylcarbonyl
pyrimidin
pyrazole
acetamide
alpha
Prior art date
Application number
DK03749163T
Other languages
Danish (da)
English (en)
Inventor
Henry R Dubois Iii
Scott E Zook
Donald Hettinger
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Application granted granted Critical
Publication of DK1532152T3 publication Critical patent/DK1532152T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
DK03749163T 2002-08-26 2003-08-26 Ny polymorf af N-methyl-N- (3- (3- [2-thienylcarbonyl]-pyrazol- [1,5-alfa]-pyrimidin-7-yl) phenyl) acetamid og beslægtede sammensætninger og metoder DK1532152T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40607202P 2002-08-26 2002-08-26
PCT/US2003/026870 WO2004018476A1 (en) 2002-08-26 2003-08-26 Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto

Publications (1)

Publication Number Publication Date
DK1532152T3 true DK1532152T3 (da) 2007-02-26

Family

ID=31946959

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03749163T DK1532152T3 (da) 2002-08-26 2003-08-26 Ny polymorf af N-methyl-N- (3- (3- [2-thienylcarbonyl]-pyrazol- [1,5-alfa]-pyrimidin-7-yl) phenyl) acetamid og beslægtede sammensætninger og metoder

Country Status (31)

Country Link
US (2) US6903106B2 (pl)
EP (1) EP1532152B1 (pl)
JP (2) JP4522859B2 (pl)
KR (1) KR101063033B1 (pl)
CN (1) CN1319974C (pl)
AP (1) AP2005003220A0 (pl)
AR (1) AR044191A1 (pl)
AT (1) ATE343581T1 (pl)
AU (1) AU2003268212B2 (pl)
BR (1) BR0313695A (pl)
CA (1) CA2493359C (pl)
DE (1) DE60309332T2 (pl)
DK (1) DK1532152T3 (pl)
EA (1) EA200500421A1 (pl)
EC (1) ECSP055703A (pl)
ES (1) ES2274260T3 (pl)
HR (1) HRP20050288A2 (pl)
IL (2) IL166621A0 (pl)
IS (1) IS7769A (pl)
MA (1) MA27519A1 (pl)
MX (1) MXPA05002251A (pl)
NO (1) NO20050615L (pl)
NZ (1) NZ538027A (pl)
OA (1) OA12917A (pl)
PE (1) PE20040979A1 (pl)
PL (1) PL374436A1 (pl)
PT (1) PT1532152E (pl)
TN (1) TNSN05058A1 (pl)
TW (1) TWI288135B (pl)
WO (1) WO2004018476A1 (pl)
ZA (1) ZA200501125B (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2005003220A0 (en) * 2002-08-26 2005-03-31 Neurocrine Biosciences Inc Novel polymorph of N-Methyl-N-(3-{3-[2-Thienylcarbonyl]-Pyrazol-[1,5-Alpha]-Pyrimidin-7-YI}Phenyl) Acetanide and compositions and methods related thereto.
US7429596B2 (en) * 2003-06-20 2008-09-30 The Regents Of The University Of California 1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
TW200630368A (en) * 2004-10-18 2006-09-01 Neurocrine Biosciences Inc Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto
CN100528875C (zh) * 2005-02-18 2009-08-19 美德（江西）生物科技有限公司 无结晶型态的印地普隆及其制备方法
EP1956021A1 (en) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
EP1918290A1 (en) * 2006-10-11 2008-05-07 Ferrer Internacional, S.A. Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
CN102180879B (zh) * 2006-11-09 2013-05-01 中国人民解放军军事医学科学院放射与辐射医学研究所 一种催眠药的多晶型α的乙酸溶剂化物
CN101177427B (zh) * 2006-11-09 2011-07-20 中国人民解放军军事医学科学院放射与辐射医学研究所 一种用于催眠的化合物的多晶型α和溶剂化物,其制备方法及含该物质的组合物
AT507187B1 (de) 2008-10-23 2010-03-15 Helmut Dr Buchberger Inhalator
CN102834987B (zh) 2010-03-25 2015-04-15 矢崎总业株式会社 接头连接器和用于识别接头连接器中的汇流条图案的方法
ES2581452T3 (es) * 2010-04-16 2016-09-05 Ivoclar Vivadent Ag Vitrocerámica y vidrio de silicato de litio con óxido de metal de transición
AT510837B1 (de) 2011-07-27 2012-07-15 Helmut Dr Buchberger Inhalatorkomponente
JP5681819B2 (ja) 2011-02-11 2015-03-11 バットマーク・リミテッド 吸入器コンポーネント
CN102174048B (zh) * 2011-03-08 2014-09-17 中国人民解放军军事医学科学院放射与辐射医学研究所 一种催眠药的新多晶型β
WO2013034459A1 (en) 2011-09-06 2013-03-14 British American Tobacco (Investments) Limited Heating smokeable material
GB201207039D0 (en) 2012-04-23 2012-06-06 British American Tobacco Co Heating smokeable material
GB2533135B (en) 2014-12-11 2020-11-11 Nicoventures Holdings Ltd Aerosol provision systems
GB201511349D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic aerosol provision systems
GB201511361D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic vapour provision system
US11924930B2 (en) 2015-08-31 2024-03-05 Nicoventures Trading Limited Article for use with apparatus for heating smokable material
US20170055584A1 (en) 2015-08-31 2017-03-02 British American Tobacco (Investments) Limited Article for use with apparatus for heating smokable material
GB2542838B (en) 2015-10-01 2022-01-12 Nicoventures Trading Ltd Aerosol provision system
US20170119046A1 (en) 2015-10-30 2017-05-04 British American Tobacco (Investments) Limited Apparatus for Heating Smokable Material
EP4706709A3 (en) 2016-04-27 2026-05-20 Nicoventures Trading Ltd ELECTRONIC AEROSOL SUPPLY SYSTEM AND ASSOCIATED SPRAYER

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6472528B1 (en) 1999-08-10 2002-10-29 Neurocrine Biosciences, Inc. Synthesis of substituted pyrazolopyrimidines
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US6485746B1 (en) * 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6384221B1 (en) * 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
KR20020035585A (ko) 1999-09-02 2002-05-11 추후기재 Ｎ-메틸-Ｎ-(3-(3-[2-티에닐카보닐]-피라졸-[1,5-α]-피리미딘-7-일)페닐)아세트아미드의 다형체 및 이와 관련된조성물과 방법
JP2001177971A (ja) * 1999-12-20 2001-06-29 Auto Network Gijutsu Kenkyusho:Kk 回転接続装置
AP2005003220A0 (en) * 2002-08-26 2005-03-31 Neurocrine Biosciences Inc Novel polymorph of N-Methyl-N-(3-{3-[2-Thienylcarbonyl]-Pyrazol-[1,5-Alpha]-Pyrimidin-7-YI}Phenyl) Acetanide and compositions and methods related thereto.

Also Published As

Publication number Publication date
PE20040979A1 (es) 2005-01-07
HK1071373A1 (en) 2005-07-15
JP4522859B2 (ja) 2010-08-11
US20040116446A1 (en) 2004-06-17
EP1532152B1 (en) 2006-10-25
BR0313695A (pt) 2005-06-21
PL374436A1 (pl) 2005-10-17
MA27519A1 (fr) 2005-09-01
EA200500421A1 (ru) 2005-08-25
DE60309332T2 (de) 2007-05-24
ECSP055703A (es) 2005-05-30
PT1532152E (pt) 2007-02-28
ES2274260T3 (es) 2007-05-16
AR044191A1 (es) 2005-09-07
WO2004018476A1 (en) 2004-03-04
JP2005538149A (ja) 2005-12-15
CN1319974C (zh) 2007-06-06
OA12917A (en) 2006-10-13
IS7769A (is) 2005-03-23
NO20050615L (no) 2005-03-22
AU2003268212B2 (en) 2008-08-14
KR101063033B1 (ko) 2011-09-07
NZ538027A (en) 2007-08-31
CA2493359C (en) 2009-10-27
ATE343581T1 (de) 2006-11-15
HRP20050288A2 (en) 2006-10-31
TWI288135B (en) 2007-10-11
KR20050059082A (ko) 2005-06-17
CN1678614A (zh) 2005-10-05
AU2003268212A1 (en) 2004-03-11
JP2010070561A (ja) 2010-04-02
TW200406404A (en) 2004-05-01
TNSN05058A1 (en) 2007-05-14
AP2005003220A0 (en) 2005-03-31
DE60309332D1 (de) 2006-12-07
CA2493359A1 (en) 2004-03-04
US6903106B2 (en) 2005-06-07
EP1532152A1 (en) 2005-05-25
US7459458B2 (en) 2008-12-02
MXPA05002251A (es) 2005-06-08
IL166621A (en) 2012-02-29
ZA200501125B (en) 2006-07-26
US20050153988A1 (en) 2005-07-14
IL166621A0 (en) 2006-01-15

Similar Documents

Publication Publication Date Title
PL374436A1 (pl) Nowa polimorficzna postać N-metylo-N-(3-{3-[2-tienylokarbonylo]pirazolo-[1,5-a]pirymidyn-7-ylo}fenylo)acetamidu, jej kompozycje i sposoby wytwarzania
ATE361279T1 (de) N-[phenyl(piperidin-2-yl)methyl]benzamidderivat , verfahren zu ihrer herstellung und ihre therapeutische anwendung
FR15C0062I2 (fr) Nouveaux derives d'oxazolidinone
NL1027811A1 (nl) Heterocyclische aminen als remmers 11- -hydroxy-steroïd-dehydrogenase type 1.
EP1667643A4 (en) NITROSED AND NITROSYLATED CARDIOVASCULAR COMPOUNDS, COMPOSITIONS AND APPLICATION METHODS
EP1420744A4 (en) AMINE COMPOUNDS AND HARDENABLE COMPOSITIONS OBTAINED THEREOF
NO20014495L (no) Ny anordning for oksygenering av sjövann
IS8324A (is) Hraðuppleysandi samsetning af kalsíum viðtaka-virku efnasambandi
NO20050741D0 (no) Ny fremgangsmate for syntesen og ny krystallinsk form av agomelatin og farmasoytiske sammensetninger inneholdende den
EP1828223A4 (en) Novel betulin derivatives, their preparation and their use
DE60307581D1 (de) Verbessertes geheimes Hashen der TCP SYN/FIN-Korrespondenz
CY2015007I1 (el) Ενωσεις, συνθεσεις και χρησεις παραγωγων βενζοθειαζολης
DE60334292D1 (de) Ylenverbundemulsionszusammensetzung und verwendung davon
DE50303492D1 (de) Überprüfung der übertragungsqualität in paketbasierten netzen
HRP20041087B8 (hr) Derivati n-acilaminobenzena kao selektivni inhibitori monoamin oksidaze b
PL1771069T3 (pl) Pochodne N-(2-(hydroksymetylo)fenylo)-1H-pirazolo-4-karboksamidu i związki pokrewne jako mikrobójcze substancje czynne do zastosowania w ochronie roślin i materiałów
DE602004010145D1 (de) Herstellung von geformten kühlmittelschläuchen
DE60121951D1 (de) Charakterisierung nichtlinearen Verhaltens
DK1214075T3 (da) Polymorfer af N-methyl-N-(3-(3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl)phenyl)acetamid og beslægtede sammensætninger og fremgangsmåder
IS2473B (is) Samsetning sem inniheldur N-(3-metoxý-5-metýlpýrasín-2-ýl)-2-(4-(1,3,4-oxadíasól-2-ýl)fenýl)pýridín-3-súlfónamíð (ZD4054), eða lyfjafræðilega viðurkennt salt þess, og EGFR TKI, eða lyfjafræðilega viðurkennt salt þess
DE60322926D1 (de) Photopolymerisierbare zusammensetzung und verwendung davon
FI20031004A0 (fi) Uusi syötävä koostumus
DE60334012D1 (de) Valerolactonverbindungen und parf mzusammensetzung
EE200300028A (et) (R)-N-[5-metüül-8-(4-metüülpiperasiin-1-üül)-1,2,3,4-tetrahüdro-2-naftüül]-4-morfolin obensamiidi uus vorm, meetod selle saamiseks ning kasutamine
ATE433466T1 (de) Herstellung von homopolymeren, copolymeren und terpolymeren aus substituierten styrolen